BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 17504522)

  • 1. Isolated receptor binding domains of HTLV-1 and HTLV-2 envelopes bind Glut-1 on activated CD4+ and CD8+ T cells.
    Kinet S; Swainson L; Lavanya M; Mongellaz C; Montel-Hagen A; Craveiro M; Manel N; Battini JL; Sitbon M; Taylor N
    Retrovirology; 2007 May; 4():31. PubMed ID: 17504522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo cellular tropism of human T-lymphotropic virus type II is not restricted to CD8+ cells.
    Lal RB; Owen SM; Rudolph DL; Dawson C; Prince H
    Virology; 1995 Jul; 210(2):441-7. PubMed ID: 7542419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HTLV-1 and -2 envelope SU subdomains and critical determinants in receptor binding.
    Kim FJ; Manel N; Garrido EN; Valle C; Sitbon M; Battini JL
    Retrovirology; 2004 Dec; 1():41. PubMed ID: 15575958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection of CD4+ T lymphocytes by the human T cell leukemia virus type 1 is mediated by the glucose transporter GLUT-1: evidence using antibodies specific to the receptor's large extracellular domain.
    Jin Q; Agrawal L; VanHorn-Ali Z; Alkhatib G
    Virology; 2006 May; 349(1):184-96. PubMed ID: 16519917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of glucose transporter 1 confers susceptibility to human T-cell leukemia virus envelope-mediated fusion.
    Coskun AK; Sutton RE
    J Virol; 2005 Apr; 79(7):4150-8. PubMed ID: 15767416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells.
    Jones KS; Fugo K; Petrow-Sadowski C; Huang Y; Bertolette DC; Lisinski I; Cushman SW; Jacobson S; Ruscetti FW
    J Virol; 2006 Sep; 80(17):8291-302. PubMed ID: 16912281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV.
    Manel N; Kim FJ; Kinet S; Taylor N; Sitbon M; Battini JL
    Cell; 2003 Nov; 115(4):449-59. PubMed ID: 14622599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose transporter 1 expression identifies a population of cycling CD4+ CD8+ human thymocytes with high CXCR4-induced chemotaxis.
    Swainson L; Kinet S; Manel N; Battini JL; Sitbon M; Taylor N
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12867-72. PubMed ID: 16126902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tax gene expression and cell cycling but not cell death are selected during HTLV-1 infection in vivo.
    Zane L; Sibon D; Jeannin L; Zandecki M; Delfau-Larue MH; Gessain A; Gout O; Pinatel C; Lançon A; Mortreux F; Wattel E
    Retrovirology; 2010 Mar; 7():17. PubMed ID: 20222966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton.
    Igakura T; Stinchcombe JC; Goon PK; Taylor GP; Weber JN; Griffiths GM; Tanaka Y; Osame M; Bangham CR
    Science; 2003 Mar; 299(5613):1713-6. PubMed ID: 12589003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HTLV-1 propels untransformed CD4 lymphocytes into the cell cycle while protecting CD8 cells from death.
    Sibon D; Gabet AS; Zandecki M; Pinatel C; Thête J; Delfau-Larue MH; Rabaaoui S; Gessain A; Gout O; Jacobson S; Mortreux F; Wattel E
    J Clin Invest; 2006 Apr; 116(4):974-83. PubMed ID: 16585963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of primary T lymphocytes results in lysosome development and polarized granule exocytosis in CD4+ and CD8+ subsets, whereas expression of lytic molecules confers cytotoxicity to CD8+ T cells.
    Shen DT; Ma JS; Mather J; Vukmanovic S; Radoja S
    J Leukoc Biol; 2006 Oct; 80(4):827-37. PubMed ID: 16891618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Dlg protein binds to the envelope glycoproteins of human T-cell leukemia virus type 1 and regulates envelope mediated cell-cell fusion in T lymphocytes.
    Blot V; Delamarre L; Perugi F; Pham D; Bénichou S; Benarous R; Hanada T; Chishti AH; Dokhélar MC; Pique C
    J Cell Sci; 2004 Aug; 117(Pt 17):3983-93. PubMed ID: 15286176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry.
    McDougal JS; Nicholson JK; Cross GD; Cort SP; Kennedy MS; Mawle AC
    J Immunol; 1986 Nov; 137(9):2937-44. PubMed ID: 2428879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Submitogenic concentrations of anti-CD3 monoclonal antibody exert antiapoptotic effects in preactivated CD4+ but not CD8+ human T cells.
    Karawajew L; Veselkov AN; Herrmann F
    Cytokines Mol Ther; 1995 Dec; 1(4):271-9. PubMed ID: 9384680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a putative cellular receptor for HTLV-I by a monoclonal antibody, Mab 34-23.
    Gavalchin J; Fan N; Lane MJ; Papsidero L; Poiesz BJ
    Virology; 1993 May; 194(1):1-9. PubMed ID: 8480413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid identification and sorting of viable virus-reactive CD4(+) and CD8(+) T cells based on antigen-triggered CD137 expression.
    Wehler TC; Karg M; Distler E; Konur A; Nonn M; Meyer RG; Huber C; Hartwig UF; Herr W
    J Immunol Methods; 2008 Nov; 339(1):23-37. PubMed ID: 18760281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry.
    Ghez D; Lepelletier Y; Lambert S; Fourneau JM; Blot V; Janvier S; Arnulf B; van Endert PM; Heveker N; Pique C; Hermine O
    J Virol; 2006 Jul; 80(14):6844-54. PubMed ID: 16809290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of HTLV-I transformed CD8+ T-cells in response to HIV-1 infection.
    Gulzar N; Shroff A; Buberoglu B; Klonowska D; Kim JE; Copeland KF
    Virology; 2010 Oct; 406(2):302-11. PubMed ID: 20708209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Processing and release of IL-16 from CD4+ but not CD8+ T cells is activation dependent.
    Wu DM; Zhang Y; Parada NA; Kornfeld H; Nicoll J; Center DM; Cruikshank WW
    J Immunol; 1999 Feb; 162(3):1287-93. PubMed ID: 9973381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.